Screener Summaries Updates Institutions Sign In More Updates › Other Events › PRNAD Other Events · Jul 7, 2026
Alterity Therapeutics received FDA meeting minutes confirming the registrational path for its lead candidate, ATH434 PRNAD Alterity Therapeutics Ltd
Alterity Therapeutics received FDA meeting minutes confirming the registrational path for its lead candidate, ATH434. The company operates in the biotechnology industry and develops therapeutic candidates for medical conditions.
More from Alterity Therapeutics Ltd All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
